Evidence map›Paper›PMID 33806614›Full record

ArticleBiomolecules2021

Mutations of Intrinsically Disordered Protein Regions Can Drive Cancer but Lack Therapeutic Strategies.

Bálint Mészáros, Borbála Hajdu-Soltész, András Zeke, Zsuzsanna Dosztányi

Abstract read
In one paragraph

Article in Biomolecules, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Review
  19. Intrinsic disorder may drive the interaction of PROS1 and MERTK in uveal melanoma.International journal of biological macromolecules · 2023
    Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Bálint MészárosDepartment of Biochemistry, ELTE Eötvös Loránd University, H-1117 Budapest, Hungary.
Borbála Hajdu-SoltészDepartment of Biochemistry, ELTE Eötvös Loránd University, H-1117 Budapest, Hungary.
András ZekeInstitute of Enzymology, RCNS, P.O. Box 7, H-1518 Budapest, Hungary.
Zsuzsanna DosztányiDepartment of Biochemistry, ELTE Eötvös Loránd University, H-1117 Budapest, Hungary.

Funding

European Molecular Biology Organization EuropaBio fellowship 7544Magyar Tudományos Akadémia LP2014-18Nemzeti Kutatási Fejlesztési és Innovációs Hivatal K108798Nemzeti Kutatási Fejlesztési és Innovációs Hivatal K129164Nemzeti Kutatási Fejlesztési és Innovációs Hivatal PD-120973
6 · The paper itself

Abstract

Many proteins contain intrinsically disordered regions (IDRs) which carry out important functions without relying on a single well-defined conformation. IDRs are increasingly recognized as critical elements of regulatory networks and have been also associated with cancer. However, it is unknown whether mutations targeting IDRs represent a distinct class of driver events associated with specific molecular and system-level properties, cancer types and treatment options. Here, we used an integrative computational approach to explore the direct role of intrinsically disordered protein regions driving cancer. We showed that around 20% of cancer drivers are primarily targeted through a disordered region. These IDRs can function in multiple ways which are distinct from the functional mechanisms of ordered drivers. Disordered drivers play a central role in context-dependent interaction networks and are enriched in specific biological processes such as transcription, gene expression regulation and protein degradation. Furthermore, their modulation represents an alternative mechanism for the emergence of all known cancer hallmarks. Importantly, in certain cancer patients, mutations of disordered drivers represent key driving events. However, treatment options for such patients are currently severely limited. The presented study highlights a largely overlooked class of cancer drivers associated with specific cancer types that need novel therapeutic options.

Indexed as

Evolution, MolecularHumansIntrinsically Disordered ProteinsMutationNeoplasmsProtein BindingProtein ConformationIntrinsically Disordered Proteinscancer genomicscancer hallmarksdriver gene identificationdrug targetsintrinsically disordered regionsmolecular switchesprotein modulesshort linear motifs

Identifiers

PMID33806614
PMCPMC8000335

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.